Published in J Clin Microbiol on September 01, 1998
Optimized PCR using patient blood samples for diagnosis and follow-up of visceral Leishmaniasis, with special reference to AIDS patients. J Clin Microbiol (2000) 2.12
Visceral leishmaniasis in Malta--an 18 year paediatric, population based study. Arch Dis Child (2000) 1.58
Use of noninvasive markers to detect Leishmania infection in asymptomatic human immunodeficiency virus-infected patients. J Clin Microbiol (2006) 1.05
Incidence of and risk factors for symptomatic visceral leishmaniasis among human immunodeficiency virus type 1-infected patients from Spain in the era of highly active antiretroviral therapy. J Clin Microbiol (2002) 0.99
Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis. Infect Immun (2002) 0.94
Noninvasive method for diagnosis of visceral leishmaniasis by a latex agglutination test for detection of antigens in urine samples. J Clin Microbiol (2004) 0.93
Importance of nonenteric protozoan infections in immunocompromised people. Clin Microbiol Rev (2010) 0.92
Unusual duodenal presentation of leishmaniasis. J Clin Pathol (2005) 0.87
Leishmaniases in Northern Greece: seroprevalence of the infection and incidence of the disease during the period 2001-2006. Eur J Clin Microbiol Infect Dis (2008) 0.86
Magnitude of visceral leishmaniasis and poor treatment outcome among HIV patients: meta-analysis and systematic review. HIV AIDS (Auckl) (2016) 0.80
Leishmaniasis at the End of the Millennium. Curr Infect Dis Rep (1999) 0.78
Prevalence of Human Immunodeficiency Virus and associated factors among Visceral Leishmaniasis infected patients in Northwest Ethiopia: a facility based cross-sectional study. BMC Infect Dis (2017) 0.75
Taxonomy of Leishmania. Use of isoenzymes. Suggestions for a new classification. Ann Parasitol Hum Comp (1990) 3.61
Comparison of PCR with direct examination of bone marrow aspiration, myeloculture, and serology for diagnosis of visceral Leishmaniasis in immunocompromised patients. J Clin Microbiol (1994) 2.04
Prevalence of Leishmania infection among AIDS patients. Lancet (1992) 1.93
Visceral leishmaniasis in patients infected with human immunodeficiency virus (HIV). Ann Intern Med (1989) 1.82
[Leishmaniasis and human immunodeficiency virus infections]. Presse Med (1995) 1.61
Visceral leishmaniasis and HIV-1 co-infection in southern France. Trans R Soc Trop Med Hyg (1995) 1.51
Epidemiological surveillance of leishmaniasis in HIV-1-infected individuals in Italy. AIDS (1996) 1.46
Prolonged Th2 cell activation and increased viral replication in HIV-Leishmania co-infected patients despite treatment. Trans R Soc Trop Med Hyg (1996) 1.19
Visceral leishmaniasis in HIV-1-infected individuals: a common opportunistic infection in Spain? AIDS (1992) 1.15
Human visceral leishmaniasis in Alpes-Maritimes, France: epidemiological characteristics for the period 1985-1992. Trans R Soc Trop Med Hyg (1994) 1.12
Visceral leishmaniasis emerging as an important opportunistic infection in HIV-infected persons living in areas nonendemic for Leishmania donovani. Arch Pathol Lab Med (1996) 1.12
Leishmaniasis eco-epidemiology in the Alpujarra region (Granada Province, southern Spain). Int J Parasitol (1996) 1.07
Visceral leishmaniasis in HIV-infected patients in the south of France. Bull World Health Organ (1995) 1.02
Frequency of subclinical visceral leishmaniasis in HIV-1-infected patients in Spain. Eur J Clin Microbiol Infect Dis (1996) 0.98
Heterogeneity among zymodemes of Leishmania infantum from HIV-positive patients with visceral leishmaniasis in south Italy. FEMS Microbiol Lett (1995) 0.96
AIDS and Leishmania infantum. New approaches for a new epidemiological problem. Clin Dermatol (1997) 0.96
Could infected drug-users be potential Leishmania infantum reservoirs? AIDS (1994) 0.91
Asymptomatic leishmaniasis in the acquired immunodeficiency syndrome (AIDS) Ann Intern Med (1989) 0.91
Low sensitivity of peripheral blood smear for diagnosis of subclinical visceral leishmaniasis in human immunodeficiency virus type 1-infected patients. J Clin Microbiol (1998) 0.89
[Visceral leishmaniasis in patients with HIV infection]. Enferm Infecc Microbiol Clin (1995) 0.87
Specificity of a commercial indirect immunofluorescence technique in the diagnosis of visceral leishmaniasis in patients infected with HIV-1. Trans R Soc Trop Med Hyg (1996) 0.86
Injecting drug use as risk factor for visceral leishmaniasis in AIDS patients. Eur J Epidemiol (1996) 0.86
Kala-azar comes to New York. Arch Intern Med (1997) 0.82
Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol (1997) 4.08
Phosphorylation of OmpR by the osmosensor EnvZ modulates expression of the ompF and ompC genes in Escherichia coli. Proc Natl Acad Sci U S A (1989) 3.19
A microsatellite genetic linkage map for zebrafish (Danio rerio). Nat Genet (1998) 3.06
[Prevalence of antibodies against hepatitis C virus in a sample of homosexual males]. Med Clin (Barc) (1993) 1.94
In vivo phosphorylation of OmpR, the transcription activator of the ompF and ompC genes in Escherichia coli. J Bacteriol (1990) 1.90
Intolerance to nonsteroidal antiinflammatory drugs: results of controlled drug challenges in 98 patients. J Allergy Clin Immunol (1996) 1.68
[Pacemaker implantation in a patient with persistent left superior vena cava and atresia of the right superior vena cava]. Rev Port Cardiol (1994) 1.66
Travelling for teeth: characteristics and perspectives of dental care tourism in Hungary. Br Dent J (2009) 1.58
Drug resistance in patients experiencing early virological failure under a triple combination including indinavir. AIDS (2001) 1.56
Regulation of ompC and ompF expression in Escherichia coli in the absence of envZ. J Bacteriol (1988) 1.51
The -250G/A polymorphism in the hepatic lipase gene promoter influences the postprandial lipemic response in healthy men. Nutr Metab Cardiovasc Dis (2007) 1.46
Lower respiratory tract respiratory virus infections increase the risk of invasive aspergillosis after a reduced-intensity allogeneic hematopoietic SCT. Bone Marrow Transplant (2009) 1.45
Outcomes of heart transplantation for cardiac amyloidosis: subanalysis of the spanish registry for heart transplantation. Am J Transplant (2009) 1.45
Insulin resistance is associated with liver stiffness in HIV/HCV co-infected patients. Gut (2009) 1.43
[Thirty-six year old male patient with dysphonia refractory to conventional medical treatment]. Enferm Infecc Microbiol Clin (2001) 1.42
NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome. Leukemia (2012) 1.41
Incidence and risk factors for tuberculosis in HIV-positive subjects by HAART status. Int J Tuberc Lung Dis (2008) 1.38
Reemergence of dengue in Cuba: a 1997 epidemic in Santiago de Cuba. Emerg Infect Dis (1998) 1.38
DNA-binding properties of the transcription activator (OmpR) for the upstream sequences of ompF in Escherichia coli are altered by envZ mutations and medium osmolarity. J Bacteriol (1989) 1.29
Sandflies of the Phlebotomus perniciosus complex: mitochondrial introgression and a new sibling species of P. longicuspis in the Moroccan Rif. Med Vet Entomol (2004) 1.26
Expression of D-type cyclins in colon cancer and in cell lines from colon carcinomas. Br J Cancer (2005) 1.25
Natural history of infection with Bartonella bacilliformis in a nonendemic population. J Infect Dis (2000) 1.22
Viral envelope protein of HTLV-III is the major target antigen for antibodies in hemophiliac patients. J Infect Dis (1986) 1.20
Pattern formation and optimization in army ant raids. Artif Life (2000) 1.20
Relationship between low bone mineral density and highly active antiretroviral therapy including protease inhibitors in HIV-infected patients. HIV Clin Trials (2003) 1.18
Anaphylaxis after ingestion of wheat flour contaminated with mites. J Allergy Clin Immunol (1997) 1.17
Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data. Bone Marrow Transplant (2010) 1.16
Visceral leishmaniasis in HIV-1-infected individuals: a common opportunistic infection in Spain? AIDS (1992) 1.15
Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in Spain. AIDS (1998) 1.14
Multiple dideoxynucleoside analogue-resistant (MddNR) HIV-1 strains isolated from patients from different European countries. AIDS (1998) 1.14
The role of serology in the diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type-1. Am J Trop Med Hyg (1998) 1.13
Plasmacytoid dendritic cells reduce HIV production in elite controllers. J Virol (2012) 1.09
Predictive value of IgM antibodies to hepatitis C virus in patients with chronic hepatitis C undergoing interferon-alpha therapy. Analysis by two different methods. J Viral Hepat (1994) 1.08
Modified immunoassays for polyether toxins: implications of biological matrixes, metabolic states, and epitope recognition. J AOAC Int (1995) 1.07
Nucleoside diphosphate kinase from Escherichia coli. J Bacteriol (1995) 1.07
Ca2(+)-enhanced phosphorylation of a chimeric protein kinase involved with bacterial signal transduction. J Biol Chem (1991) 1.04
High frequency of serious side effects from meglumine antimoniate given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodeficiency virus type-1-infected patients. Am J Trop Med Hyg (1999) 1.03
An easy and quick method for the diagnosis of visceral leishmaniasis in HIV-1-infected individuals. AIDS (1993) 1.02
Differential diagnosis of Taenia saginata and Taenia solium with DNA probes. Parasitology (1990) 1.01
Sonicated diagnostic immunoblot for bartonellosis. Clin Diagn Lab Immunol (2000) 1.00
Cystic teratoma of the mesentery. Pediatr Radiol (1989) 1.00
CD4+ and CD8+ T lymphocyte regeneration after anti-retroviral therapy in HIV-1-infected children and adult patients. Clin Exp Immunol (2000) 0.99
[Epidemiology of dengue and hemorrhagic dengue in Santiago, Cuba 1997]. Rev Panam Salud Publica (1999) 0.98
Intraspecific variation in retinal cone distribution in the bluefin killifish, Lucania goodei. J Comp Physiol A Neuroethol Sens Neural Behav Physiol (2003) 0.98
Frequency of subclinical visceral leishmaniasis in HIV-1-infected patients in Spain. Eur J Clin Microbiol Infect Dis (1996) 0.98
Unexpected high prevalence of hepatitis C virus genotype 4 in Southern Spain. J Hepatol (1997) 0.97
Modulation of GT-1 DNA-binding activity by calcium-dependent phosphorylation. Plant Mol Biol (1999) 0.97
Influence of human immunodeficiency virus type 1 infection on the natural course of chronic parenterally acquired hepatitis C. Eur J Clin Microbiol Infect Dis (1995) 0.96
Sorafenib inhibits MAPK-mediated proliferation in a Barrett's esophageal adenocarcinoma cell line. Dis Esophagus (2008) 0.95
Prevalence and factors associated with significant liver fibrosis assessed by transient elastometry in HIV/hepatitis C virus-coinfected patients. J Viral Hepat (2010) 0.95
Systemic and lung physiological changes in rats after intravascular activation of complement. J Appl Physiol (1985) (2001) 0.95
The high sensitivity of a PCR-ELISA in the diagnosis of cutaneous and visceral leishmaniasis caused by Leishmania infantum. Ann Trop Med Parasitol (2002) 0.94
Hepatitis C virus replication in Caucasian HIV controllers. J Viral Hepat (2011) 0.94
Hepatitis B virus occult infection in subjects with persistent isolated anti-HBc reactivity. J Hepatol (1993) 0.93
Climatic factors and Pneumocystis jiroveci infection in southern Spain. Clin Microbiol Infect (2004) 0.93
Effect of ribavirin on intracellular and plasma pharmacokinetics of nucleoside reverse transcriptase inhibitors in patients with human immunodeficiency virus-hepatitis C virus coinfection: results of a randomized clinical study. Antimicrob Agents Chemother (2005) 0.93
Thymic volume is associated independently with the magnitude of short- and long-term repopulation of CD4+ T cells in HIV-infected adults after highly active antiretroviral therapy (HAART). Clin Exp Immunol (2004) 0.93
Involvement of lipid rafts in the localization and dysfunction effect of the antitumor ether phospholipid edelfosine in mitochondria. Cell Death Dis (2011) 0.92
Liver toxicity of antiretroviral combinations including atazanavir/ritonavir in patients co-infected with HIV and hepatitis viruses: impact of pre-existing liver fibrosis. J Antimicrob Chemother (2008) 0.92
Different distributions of hepatitis C virus genotypes among HIV-infected patients with acute and chronic hepatitis C according to interleukin-28B genotype. HIV Med (2011) 0.92
Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain. The ERASE-2 Study Group. AIDS (2000) 0.91
Study of the burden on patients with chronic obstructive pulmonary disease. Int J Clin Pract (2009) 0.91
Tobacco smoke-induced lung emphysema in guinea pigs is associated with increased interstitial collagenase. Am J Physiol (1996) 0.90
Consensus conference on chronic viral hepatitis and HIV infection: updated Spanish recommendations. J Viral Hepat (2004) 0.90
Risk maps for the presence and absence of Phlebotomus perniciosus in an endemic area of leishmaniasis in southern Spain: implications for the control of the disease. Parasitology (2011) 0.90
Larval anisakids parasitizing the blue whiting, Micromesistius poutassou, from Motril Bay in the Mediterranean region of southern Spain. J Helminthol (2000) 0.90
Influence of hepatitis C virus infection on the mortality of antiretroviral-treated patients with HIV disease. Eur J Clin Microbiol Infect Dis (1998) 0.89
Usefulness of route of transmission, absolute CD8+ T-cell counts, and levels of serum tumor necrosis factor alpha as predictors of survival of HIV-1-infected patients with very low CD4 + T-cell counts. Eur J Clin Microbiol Infect Dis (2001) 0.89
Zinc alpha-2 glycoprotein is implicated in dyslipidaemia in HIV-1-infected patients treated with antiretroviral drugs. HIV Med (2012) 0.89
Changes in the rate of genotypic resistance to antiretroviral drugs in Spain. AIDS (2001) 0.89
Low sensitivity of peripheral blood smear for diagnosis of subclinical visceral leishmaniasis in human immunodeficiency virus type 1-infected patients. J Clin Microbiol (1998) 0.89
Is hepatitis G virus transmitted sexually? JAMA (1997) 0.89
Isolation of the Pichia pastoris PYC1 gene encoding pyruvate carboxylase and identification of a suppressor of the pyc phenotype. Yeast (1998) 0.89